• May 12, 2020  

    Pancreatic Cancer Survival Rates: What Do They Really Mean?

    Lola Rahib, PhD

    The American Cancer Society estimates that in 2020, 57,600 people in the U.S. will be diagnosed with pancreatic cancer and 47,050 will die from the disease. But not everyone’s pancreatic cancer is the same. Understanding what survival rates mean—and which factors can impact them—could help you navigate your or your loved one’s disease. What is the five-year relative survival rate for pancreatic cancer? In… Read more »

  • February 22, 2020  

    Accelerating Children’s Access to New Treatments for High Risk Brain Tumors Bookmark

    George Lundberg, MD

    Article from Michigan Health Lab curated by Editor in Chief George Lundberg, MD, who notes: 

    Children with serious brain tumors need access to as many clinical trials as possible. This new consortium will encourage that.

    Go to full article published by Michigan Health Lab.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  • February 11, 2020  

    Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline Bookmark

    George Lundberg, MD

    Research paper from the Journal of Clinical Oncology curated by Editor in Chief George Lundberg, MD, who notes: 

    There has been confusion about how to conduct follow-up for a patient with lung cancer who has received therapy intended to cure. This new guideline intends to clarify best practice.

    Go to full paper published in the Journal of Clinical Oncology.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  • December 13, 2019  

    Esophageal Cancer Treatment (Adult) (PDQ®)–Patient Version Bookmark

    George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD, who notes:

    Esophageal cancer is common and difficult to treat; causation, classification and diagnosis are evolving. Read here a patient-friendly overview of the disease from the U.S. National Cancer Institute.

    .

  • December 13, 2019  

    Cervical Cancer – Overview Bookmark

    George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD, who notes:

    The third leading cause of cancer death of women in developing countries, advanced cervical cancer is relatively rare in the U.S. This comprehensive review summarizes it nicely.

    .

  • September 16, 2019  

    Fixed and Variable Factors that Impact a Brain Tumor Patient’s Prognosis

    George Lundberg, MD

    A Q&A with Burt Nabors, MD, Professor and Director of the Division of Neuro-oncology at the University of Alabama, Birmingham, and a member of the Cancer Commons Brain Tumor Advisory Board; bnabors@uabmc.edu Q: Primary brain gliomas can be devastating, often deadly, malignancies. Obvious prognostic factors include whether they are grade 1, 2, 3, or 4; their extent of growth prior to diagnosis (stage); and… Read more »

  • September 6, 2019  

    What Questions Should I Ask My Doctor?

    Cancer Commons ScientistsSarah Stanley

    When faced with an advanced cancer diagnosis, it can be difficult to know what questions to ask. At Cancer Commons, we help patients and caregivers navigate a vast sea of cancer information so they can work with their doctor to pinpoint their best possible treatment plan. Based on our Scientists’ many years of experience helping patients and caregivers around the world, here are some… Read more »

  • August 17, 2019  

    Non-Hodgkin Lymphoma—Overview Bookmark

    George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD, who notes:

    Malignancies of lymphoid tissues are broadly named “lymphoma.” There are many categories and subcategories. Here is a broadly based report about non-Hodgkin lymphomas, published by Medscape in 2019.

     

  • August 17, 2019  

    Diffuse Intrinsic Pontine Glioma (DIPG)—An Overview Bookmark

    George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD, who notes:

    DIPG is a rare, malignant brain tumor. Three hundred Americans, usually children, are diagnosed with DIPG each year. Its location (pons), its sublocation (intrinsic), its growth character (diffuse), and its cell type (glioma) describe a very difficult cancer to treat. Here is how one prestigious cancer center (Dana-Farber Cancer Institute) explains DIPG.

    .

  • August 17, 2019  

    Malignant Melanoma—An Overview Bookmark

    George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD, who notes:

    Malignant melanoma is a fairly common, usually cutaneous, potentially lethal malignancy, and precision oncology has demonstrated some dramatic successes for treatment of its advanced stages. If you wish to learn more, this 2019 encyclopedic discourse from Medscape is solid, current, unbiased, and sensible.